Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) shares saw unusually-high trading volume on Monday . Approximately 251,015 shares changed hands during trading, an increase of 35% from the previous session's volume of 186,035 shares.The stock last traded at $33.15 and had previously closed at $32.65.
Wall Street Analyst Weigh In
SLP has been the subject of several research reports. KeyCorp boosted their price target on Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a research report on Wednesday. StockNews.com cut shares of Simulations Plus from a "hold" rating to a "sell" rating in a research report on Monday, April 14th. Finally, William Blair restated an "outperform" rating on shares of Simulations Plus in a research report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $50.00.
Check Out Our Latest Stock Analysis on SLP
Simulations Plus Stock Performance
The stock has a market cap of $657.43 million, a PE ratio of 81.73 and a beta of 1.13. The stock's 50-day moving average is $28.55 and its two-hundred day moving average is $30.09.
Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.25 by $0.06. The business had revenue of $22.43 million during the quarter, compared to analyst estimates of $21.93 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The business's revenue for the quarter was up 22.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.20 earnings per share. Analysts forecast that Simulations Plus, Inc. will post 1.09 EPS for the current year.
Insider Buying and Selling at Simulations Plus
In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the firm's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $33.91, for a total transaction of $678,200.00. Following the transaction, the director now directly owns 3,402,584 shares of the company's stock, valued at approximately $115,381,623.44. This trade represents a 0.58 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 19.40% of the stock is owned by insiders.
Institutional Trading of Simulations Plus
Hedge funds have recently modified their holdings of the business. Jones Financial Companies Lllp increased its holdings in shares of Simulations Plus by 53.6% in the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock valued at $34,000 after purchasing an additional 427 shares in the last quarter. Fifth Third Bancorp lifted its position in shares of Simulations Plus by 33.8% during the 1st quarter. Fifth Third Bancorp now owns 1,485 shares of the technology company's stock valued at $36,000 after acquiring an additional 375 shares during the period. Johnson Financial Group Inc. purchased a new stake in shares of Simulations Plus during the 4th quarter worth approximately $39,000. Tower Research Capital LLC TRC grew its holdings in shares of Simulations Plus by 42.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock worth $72,000 after acquiring an additional 764 shares during the period. Finally, AlphaQuest LLC increased its stake in Simulations Plus by 502.9% in the 4th quarter. AlphaQuest LLC now owns 2,689 shares of the technology company's stock valued at $75,000 after purchasing an additional 2,243 shares in the last quarter. 78.08% of the stock is owned by institutional investors and hedge funds.
About Simulations Plus
(
Get Free Report)
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Featured Stories
Before you consider Simulations Plus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Simulations Plus wasn't on the list.
While Simulations Plus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
